shared cancer care: modeling collaboration …...10 oe vol. 15, no. 2, may 2016 comment shared...

2
10 oe VOL. 15, NO. 2, MAY 2016 COMMENT Shared cancer care: modeling collaboration between oncologist and family physician Dr. Jean Maroun, Editor-in-Chief A t the inaugural Cancer Survivorship Symposium held in January 2016, Professor Bijal Balasubramanian from the division of epidemiology, human genetics, and environmental science at the University of Texas presented results of a survey on who should assume responsibility for survivorship care. 1 It revealed that 41% of primary care phy- sicians (PCP) preferred an oncologist-led care delivery model (as compared to 21% of oncologists), and 56% dis- agreed that PCPs should have primary responsibility for providing cancer followup care. The survey was conducted in a US care setting distinct in that it served uninsured patients and had a shared electronic health record system and clinical infrastructure that facilitated communication and coordination. Interestingly, the PCPs unwillingness to take the lead was not associated with a perceived lack of ability: 73% (along with 58% of oncologists) felt that PCPs had the skills required for cancer surveillance. Worryingly, oncologists more consistently reported that PCPs ordered tests for cancer surveillance, evaluated patients for cancer recurrence and for adverse physical and psychological effects of cancer or its treatment, as well as managed pain and adverse outcomes of cancer treatment, than PCPs themselves reported ordering, suggesting that patients may not consistently be receiving recommended followup care. Dr. Balasubramanian concluded that, while is seems inevitable and desirable that cancer survivorship care increasingly involve PCPs, their practice needs to become much stronger than it has been until now. Better communi- cation between oncologists and PCPs through treatment summaries and personalized care plans may help, and con- sensus guidelines are needed to delineate shared responsi- bilities for cancer survivors between primary care and oncology specialty care physicians. This study highlights challenges we face in Canada as well, and reveals that we have a lot of work ahead of us. Previous research in the US context had found significant differences between PCP and oncologist attitudes and prac- tices with respect to care of cancer survivors and called for more effective communication and coordination to improve care. What is striking about this most recent study is that even in a context that facilitates communication and coordination, there is a persistent discrepancy between oncologist and PCP views on who should take the lead in cancer survivor- ship care and misunderstanding about who is doing what. According to Dr. Balasubramanian, the interest in shared care models makes sense as a means of benefiting from primary care physician expertise in chronic diseases, which are often present in older cancer patients, and oncologist expertise in cancer-related issues. THE CANCER POPULATION “A cancer survivor is anyone who has been diagnosed with cancer, from the time of initial diagnosis and treatment through the remaining years of life. The goal of survivor- ship care is to prevent, detect, and manage complications that arise from cancer or cancer treatments and to improve overall health and quality of life for survivors.” 2 According to Canadian Cancer Society projections, the number of new diagnoses per year will increase from about 197,000 now to 277,000 a year in 2030. And based on 2006–2008 estimates, 63% of Canadians diagnosed with cancer are expected to survive for 5 years or more after a cancer diagnosis. There is considerable variation between cancers with regard to long-terms survival, with 5-year sur- vival rates of 96% in prostate cancer, 88% in breast cancer and 64% in colorectal cancer. Survival rates in other cancer are increasing quickly. At the beginning of 2005, there were 695,000 people living with a cancer that had been diagnosed sometime in the previous 10 years, and this fig- ure represents only a fraction of the total survivor popula- tion. Post-cancer support and treatment can vary widely between and within provinces. 3,4 Along with increases numbers of cancer survivors who require ongoing care for general health issues, late treat- ment effects, and monitoring for recurrence, increasing Dr. Jean Maroun currently works as oncologist at the St. Laurent Medical Centre in Ottawa, where family physicians, medical and radiation oncologists collaborate to provide diagnosis of suspected cancers, followup of previously diagnosed cancers, and post-discharge support. The Centre also offers routine care for other health problems and a walk-in clinic. Better communication between oncologists and PCPs through treatment summaries and personalized care plans may help, and consensus guidelines are needed to delineate shared responsibilities for cancer survivors between primary care and oncology specialty care physicians

Upload: others

Post on 31-Jan-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Shared cancer care: modeling collaboration …...10 oe VOL. 15, NO. 2, may 2016 comment Shared cancer care: modeling collaboration between oncologist and family physician Dr. Jean

10 oe VOL. 15, NO. 2, may 2016

comment

Shared cancer care: modeling collaboration between oncologist and family physicianDr. Jean Maroun, Editor-in-Chief

at the inaugural Cancer Survivorship Symposium held in January 2016, Professor Bijal Balasubramanian from the division of epidemiology, human genetics, and

environmental science at the University of Texas presented results of a survey on who should assume responsibility for survivorship care.1 It revealed that 41% of primary care phy-sicians (PCP) preferred an oncologist-led care delivery model (as compared to 21% of oncologists), and 56% dis-agreed that PCPs should have primary responsibility for providing cancer followup care. The survey was conducted in a US care setting distinct in that it served uninsured patients and had a shared electronic health record system and clinical infrastructure that facilitated communication and coordination. Interestingly, the PCPs unwillingness to take the lead was not associated with a perceived lack of ability: 73% (along with 58% of oncologists) felt that PCPs had the skills required for cancer surveillance. Worryingly, oncologists more consistently reported that PCPs ordered tests for cancer surveillance, evaluated patients for cancer recurrence and for adverse physical and psychological effects of cancer or its treatment, as well as managed pain and adverse outcomes of cancer treatment, than PCPs themselves reported ordering, suggesting that patients may not consistently be receiving recommended followup care.

Dr. Balasubramanian concluded that, while is seems inevitable and desirable that cancer survivorship care increasingly involve PCPs, their practice needs to become much stronger than it has been until now. Better communi-cation between oncologists and PCPs through treatment summaries and personalized care plans may help, and con-sensus guidelines are needed to delineate shared responsi-bilities for cancer survivors between primary care and oncology specialty care physicians.

This study highlights challenges we face in Canada as well, and reveals that we have a lot of work ahead of us. Previous research in the US context had found significant differences between PCP and oncologist attitudes and prac-tices with respect to care of cancer survivors and called for more effective communication and coordination to improve care. What is striking about this most recent study is that even in a context that facilitates communication and coordination, there is a persistent discrepancy between oncologist and

PCP views on who should take the lead in cancer survivor-ship care and misunderstanding about who is doing what.

According to Dr. Balasubramanian, the interest in shared care models makes sense as a means of benefiting from primary care physician expertise in chronic diseases, which are often present in older cancer patients, and oncologist expertise in cancer-related issues.

The cancer populaTion“A cancer survivor is anyone who has been diagnosed with cancer, from the time of initial diagnosis and treatment through the remaining years of life. The goal of survivor-ship care is to prevent, detect, and manage complications that arise from cancer or cancer treatments and to improve overall health and quality of life for survivors.”2

According to Canadian Cancer Society projections, the number of new diagnoses per year will increase from about 197,000 now to 277,000 a year in 2030. And based on 2006–2008 estimates, 63% of Canadians diagnosed with cancer are expected to survive for 5 years or more after a cancer diagnosis. There is considerable variation between cancers with regard to long-terms survival, with 5-year sur-vival rates of 96% in prostate cancer, 88% in breast cancer and 64% in colorectal cancer. Survival rates in other cancer are increasing quickly. At the beginning of 2005, there were 695,000 people living with a cancer that had been diagnosed sometime in the previous 10 years, and this fig-ure represents only a fraction of the total survivor popula-tion. Post-cancer support and treatment can vary widely between and within provinces.3,4

Along with increases numbers of cancer survivors who require ongoing care for general health issues, late treat-ment effects, and monitoring for recurrence, increasing

Dr. Jean Maroun currently works as oncologist at the St. Laurent medical Centre in Ottawa, where family physicians, medical and radiation oncologists collaborate to provide diagnosis of suspected cancers, followup of previously diagnosed cancers, and post-discharge support. The Centre also offers routine care for other health problems and a walk-in clinic.

Better communication between oncologists and PCPs through treatment summaries and personalized care plans may help, and consensus guidelines are needed to delineate shared responsibilities for cancer survivors between primary care and oncology specialty care physicians

Page 2: Shared cancer care: modeling collaboration …...10 oe VOL. 15, NO. 2, may 2016 comment Shared cancer care: modeling collaboration between oncologist and family physician Dr. Jean

oe VOL. 15, NO. 2, may 2016 11

numbers of cancer treatments are being provided in the outpatient setting, prompting greater need for community-based care providers equipped to follow patients on active treatment. End-of-life care is another area of expanding need that governments want to see met in the community rather than hospital centres.

reThinking The cancer care workforceIn 2015, there were a total of 517 medical oncologists in Canada, a rate per 100,000 population which has doubled since 1995 to a national average of 1.4. There are signifi-cant provincial differences, with four provinces (PEI, New Brunswick, Manitoba, Saskatchewan) and the Territories counting less than 1 medical oncologist per 100,000 popu-lation. Looking at future supply, there are 150 postgraduate MD trainees in medical oncology in Canada’s 17 medical schools (though none at Memorial in Newfoundland, University of Saskatchewan or the Northern Ontario School of Medicine). About 40 medical oncology trainees com-pleted postgraduate training each year across Canada.6 The total number of family physicians in Canada stands at 40,571 (2015) or 114/100,000, with number higher in provinces with fewer oncologists (168/100,000 in Nfld; 140 in PEI and 149 in NB). While 65% of Canadian medical oncologists work in academic health centres; 67% of family physicians work in private offices or community clinics.5 The Canadian Association of Nurses in Oncology had 866 members as of September 2015, 22% of whom had upwards of 20 years experience in oncology nursing.7 We will need to better combine the expertise and availability of different professionals to meet the cancer care challenge.

In February 2015, Oncology Exchange published an arti-cle by Brigden et al encouraging the development of com-munity oncology practice — that is oncologists working outside of major hospital centres — to palliate the current concentration of oncology specialists in major urban cen-tres and support delivery care close to home. The authors reported results of a survey of 6 dynamic community oncology practices across Canada and described an optimal model in which care was shared between a community oncologist, GP in oncology, nurse practitioner in oncology, nurse navigator and pharmacist.8

Models of care such as these, adapted to a wide variety of settings, are required to care for the large and growing population of cancer patients and cancer survivors. Steps are already being taken to increase family physician knowledge about the chemotherapy regimens used in different disease sites, management of treatment side effects, including late radiation effects, symptom management, and distress coun-selling. For example, the University of Ottawa offers a family practice oncology program, with rotations in hematologic oncology, gynecologic oncology, radiation oncology, in-patient and outpatient medical oncology, and palliative care. Cancer Care Ontario (CCO) is working to integrate primary care physicians into all steps along the cancer journey, from screening through to palliative care and each Local Health Integration Network (LHIN) now has primary care cancer leads working to meaningfully engage PCPs in cancer care.

The BC Cancer Agency’s Family Practice Oncology Net-work (FPON) works to develop oncology related clinical practice guidelines for use in primary care.

Dr. Malcolm Moore, recently appointed head of the BC Cancer Agency, recognized the challenges in a recent editorial:

“Family physicians already play a major role in cancer screening and prevention, for example, but there is oppor-tunity for greater involvement in followup care and in meeting the survivorship needs of patients who have com-pleted treatment. We need to engage in a dialogue about how to most effectively transition to this approach, how best the Cancer Agency can support primary care providers who deal with cancer patients and to ensure we have a funding model to support this new reality.”9

This is an issue that will become more pressing in the next few years. In August Oncology Exchange will include a look at the model we are working towards in our Ottawa clinic, and Dr. Malcolm Brigden will look at how one community clinic is meeting the challenge posed by new agents such as immune checkpoint inhibitors.

reference1. Balasubramanian, Bijal A., Katelyn K. Jetelina, and Simon Craddock Lee.

“Oncologist and primary care physician attitudes and practices toward cancer survivor follow-up care in an integrated health system.” In ASCO Annual Meeting Proceedings, 2016; 34(3 suppl):105.

2. Boland, Genevieve Marie, and Jeffrey E. Gershenwald. “Melanoma Survivorship Management.” Advances in Cancer Survivorship Management. Houston: U of Texas MD Anderson Cancer Center, 2015. 220-37. Springer. Web. 21 July 2015.

3. Canadian Cancer Society, Cancer Statistics at a glance. 4. Canadian Cancer Society. The Fight For Life: Nationwide Strategic Plan 2010-2015.5. CMA Masterfile Medical Oncology Profile / Masterfile Family physicians 6. 2014/15 Annual Census of Post-MD Trainees, CAPER7. CANO 2015 Annual Report 8. Brigden M, Lam W, Spadafora S, et al. Update on community oncology practice

in Canada: A view from the trenches. Oncology Exchange 2015: 1:15.9. Journal of Family Practice Oncology, Fall 2015.

comment

Call for manuscript submissions on collaborative care models

Oncology Exchange will continue to explore this challenge in the November 2016 issue and invites submissions from health professionals that:• present innovative models and initiatives• forecast future needs• discuss barriers and facilitators to collaboration• describe lessons from other disease areas

manuscripts may be submitted electronically for review. There is no author fee for submissions. The deadline is September 1, 2016.

Please send manuscripts to: [email protected]

For full submission guidelines, please see www.oncologyex.com